Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Cord blood Stories

2013-12-04 08:30:33

SAN BRUNO, Calif. and PARSIPPANY, N.J., Dec. 4, 2013 /PRNewswire-USNewswire/ -- Cord Blood Registry® (CBR) and the U.S. Women's Health Alliance announced today their partnership on a nationwide patient education and quality initiative to ensure all expectant parents understand their options regarding umbilical cord stem cell collection and possibly improve medical outcomes for their families. Together, the Alliance and CBR will educate parents on umbilical cord and tissue banking...

2013-12-03 08:32:40

GREENWOOD VILLAGE, Colo., Dec. 3, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the joining of two prominent scientists in the field of molecular biology and stem cell research to its SAB. (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Michael Macaluso, Ampio's CEO, noted "The company is currently advancing three drugs (Ampion((TM)), Optina((TM)) and Zertane((TM))) and one diagnostic device (ORP) through clinical trials and...

2013-11-21 20:21:30

DUBLIN, November 22, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pnwrhb/complete_201314) has announced the addition of the "Complete 2013-14 U.S. Cord Blood Banking Industry Report" [http://www.researchandmarkets.com/research/pnwrhb/complete_201314 ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The cord blood banking...

2013-11-19 16:25:55

Saving lives for half a century with innovative blood products, research and technology NEW YORK, Nov. 19, 2013 /PRNewswire/ -- At a gala event Monday evening, Rafaello Carone, 12, took the stage at the Waldorf Astoria dressed to the nines in a neatly pressed suit and blood-red shirt and tie. (Photo: http://photos.prnewswire.com/prnh/20131119/NY20258-a) (Photo: http://photos.prnewswire.com/prnh/20131119/NY20258-b) His appearance at the event, celebrating the start of New York...

2013-11-14 08:34:16

Company Generated Record 2013 YTD Cash from Operations of $333,034, Up 247% or $560,000 from the Year Ago Period LAS VEGAS, Nov. 14, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended September 30, 2013. Third Quarter and YTD 2013 Highlights from Continuing Operations -- Third quarter recurring revenues increased 8% to $684,374 compared to the year...

2013-11-07 08:30:44

Earnings Call Scheduled for 8:00 a.m. ET on November 15, 2013 HONG KONG, Nov. 7, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2014 on Thursday, November 14, 2013, after market close in the US. The Company will host a conference call at 8:00 a.m. ET on Friday, November 15, 2013 to discuss its financial performance and give a brief...

2013-11-06 12:28:08

Americord applauds advancement of new stem cell expansion technology NEW YORK, Nov. 6, 2013 /PRNewswire/ -- A few weeks ago, the Harvard Stem Cell Institute (HSCI) announced promising results in a new approach to improving the success of cord blood stem cell transplants. In HCSI's human clinical trial, scientists provided stem cell transplants to 12 patients using cord blood stem cells that had been treated with a molecule known as 16-dimethyl prostaglandin E2 (dmPGE2). The molecule...

2013-11-05 23:04:29

Reportbuyer.com just published a new market research report: Stem Cell Markets. London (PRWEB) November 05, 2013 A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide...

2013-11-01 23:00:51

Stem cells from AlphaCord labs are being used in vital clinical trials to treat autism, brain injuries, cerebral palsy and even juvenile diabetes. The company is celebrating this accomplishment by offering parents $495 umbilical cord blood processing during the month of November. Atlanta, GA (PRWEB) November 01, 2013 AlphaCord, a private blood bank with over a decade of experience, reached an important milestone. Their laboratories recently released their 495th unit of umbilical cord...

2013-10-30 23:22:19

STEMSOFT Software Inc. (“STEMSOFT”) is pleased to announce that the Center for International Blood & Marrow Transplant Research (CIBMTR®) has certified STEMSOFTconnect: REGISTRY to electronically submit all available forms using the CIBMTR AGNIS system. Vancouver, BC (PRWEB) October 30, 2013 STEMSOFT Software Inc. (“STEMSOFT”) is pleased to announce that the Center for International Blood & Marrow Transplant Research (CIBMTR®) has certified STEMSOFTconnect:...